Intel: Why I Believe The Market Can Continue Paying A Premium

Intel was reiterated as a buy with a $176 price target, implying 33% upside from the current $132 level. The bullish case is driven by DCAI growth from inference and agentic AI, stronger advanced packaging demand tied to AI chip complexity, foundry loss reduction, and stable CCG performance. The analyst lifted 2028 adjusted EPS potential to $2.07, signaling improving long-term fundamentals.

Analysis

The setup is less about a one-quarter AI pop and more about a multi-year operating leverage inflection: if Intel can turn its manufacturing/friction costs into an AI-enabling asset, incremental gross margin can expand faster than revenue. The second-order winner is not just the chip business itself but the packaging/tooling ecosystem, where constrained advanced packaging capacity tends to shift bargaining power toward whichever suppliers can secure long-duration orders and design-ins. That creates a subtle competitive read-through for peers that are structurally dependent on external foundry capacity or less integrated packaging stacks.

The market is still underestimating how much of the upside can come from cost absorption rather than top-line heroics. A modest improvement in foundry losses and utilization can disproportionately lift EPS because fixed-cost leverage is so high; the key variable is whether management can sustain mix improvement while keeping capex from outrunning cash generation. If AI inference demand proves sticky and less cyclical than training, Intel’s server exposure becomes a steadier monetization path than the consensus expects, especially over the next 12-24 months.

The main risk is that this remains a story stock until operating metrics prove it is a cash-flow story. Any slip in execution on manufacturing ramp, packaging capacity, or client demand would quickly compress the implied 2028 bridge, because the valuation is front-running an earnings step-up that is still several budget cycles away. The contrarian view is that the stock may be cheap for a reason: the market could be discounting structural dilution from capex, execution risk, and the possibility that AI share gains accrue to ecosystem peers rather than Intel’s core franchise.

Catalyst-wise, the next 1-3 quarters matter for confidence, but the real re-rating requires 6-18 months of evidence on gross margin, foundry loss trajectory, and AI-related design wins. If those data points inflect, the stock can rerate well before the 2028 EPS target becomes relevant; if they do not, downside is likely driven by multiple compression rather than earnings revisions.

Key Decisions for Investors

• Long INTC on a 3-6 month horizon, but only on pullbacks or post-earnings confirmation of margin/foundry trajectory; target a 20-30% move if the market starts pricing the 2028 EPS bridge.
• Use a call spread in INTC (6-12 months) instead of stock for defined risk: the thesis needs upside convexity, while execution risk limits straight-equity conviction.
• Pair long INTC vs short a higher-multiple AI infrastructure name with weaker manufacturing optionality over 6-12 months; the goal is to isolate operating-leverage rerating from broad AI beta.
• If packaging or foundry commentary deteriorates for two consecutive quarters, reduce exposure by 50%: the thesis breaks first through margin, not revenue.
• For event-driven traders, buy INTC into earnings only if there is clear guidance on utilization/mix; otherwise wait for post-print volatility to avoid paying for an execution premium.